CorMedix
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CorMedix and other ETFs, options, and stocks.About CRMD
CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E.
CRMD Key Statistics
Stock Snapshot
CorMedix(CRMD) stock is priced at $11.33, giving the company a market capitalization of 896.35M. It carries a P/E multiple of 5.56.
On 2025-11-14, CorMedix(CRMD) stock moved within a range of $11.13 to $11.97. With shares now at $11.33, the stock is trading +1.8% above its intraday low and -5.4% below the session's peak.
Trading activity shows a volume of 5.98M, compared to an average daily volume of 3.47M.
The stock's 52-week range extends from a low of $5.60 to a high of $17.43.
The stock's 52-week range extends from a low of $5.60 to a high of $17.43.
CRMD News
On November 12, 2025, CorMedix Inc. reported a very large year-over-year increase in third quarter revenue to US$104.28 million and net income of US$108.56 mill...
Cormedix Inc. ( (CRMD) ) has released its Q3 earnings. Here is a breakdown of the information Cormedix Inc. presented to its investors. Meet Your ETF AI Analys...
Cormedix Inc. ((CRMD)) has held its Q3 earnings call. Read on for the main highlights of the call. Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analys...
Analyst ratings
100%
of 7 ratingsMore CRMD News
CorMedix Inc. (NASDAQ:CRMD) reported third-quarter earnings of $1.26 per share on Wednesday, beating the consensus of 63 cents. Sales reached $104.27 million,...
Earnings Call Insights CorMedix raises 2025 revenue guidance to $390M-$410M amid accelerated Melinta integration and DefenCath momentum Nov. 12, 2025 11:12 AM E...
Wondering if CorMedix is a hidden gem or if its price already reflects the opportunity? Let’s break down the numbers and see what the latest figures are really...
CorMedix (CRMD) shares have experienced modest movement lately, drawing attention from investors curious about its recent performance and longer-term prospects....